SOURCE: Health2o Products, LLC

Health2o Products, LLC

January 20, 2010 05:00 ET

Internationally Respected Bio-Technology Firm to Conduct Advanced Scientific Testing and Evaluation for Health2o Products, LLC

DALLAS, TX--(Marketwire - January 20, 2010) - FutureCeuticals®, an internationally respected bio-technology firm, has signed a multi-year, multi-million dollar Cooperative Research and Development Agreement with Health2o Products, LLC of Dallas. Known for their innovations in research and development of consumer health products, FutureCeuticals will conduct research on production optimization of the Health2o Archaea Active™ formula and proprietary manufacturing processes. In addition, they will complete extensive, long-range scientific analysis and studies in clinico for the products currently being manufactured and in development by Health2o Products.

Initial product research and in vitro testing has supported the scientific promise of Health2o's all natural Archaea Active formula. It is believed that the formula is involved with specific cell signaling processes that stimulate other cells to take human health protective responses.

"FutureCeuticals' research will contribute to our goals for optimizing our technology platform and manufacturing processes," said Kevin D. Kuykendall, chairman and CEO of Health2o Products, LLC. "We selected FutureCeuticals because of their experience, specialized manufacturing knowledge and innovative scientific research and development techniques."

At the direction of Health2o, FutureCeuticals will initiate advanced chemistry and bio-testing protocols utilizing high-tech analytical tools and published methods. The range of research goals include chemical and physical characterization of the active components, as well as ex vivo screening followed by exploratory clinical studies to identify its effect and functionality in humans. Studies will target cellular regeneration, oxygen and energy metabolism, and inflammatory responses.

"We quickly recognized that Health2o has assembled a dynamic and talented group of people, and their Archaea Active technology is showing great promise," said John M. Hunter, general manager of FutureCeuticals. "We're excited to have the opportunity to integrate our manufacturing capabilities, scientific knowledge and experience into the Health2o effort -- from the sourcing of raw materials to the careful bio-testing."

About Health2o Products, LLC and Archaea Active™

Health2o Products, LLC is a Dallas-based health and wellness company formed in 2008 to complete scientific research and perform advanced testing on the Company's Archaea Active™ formula, proprietary manufacturing process, and products. The Company's flagship product, Evolv™, is an enhanced water distributed by EvolvHealth. Archaea Active™ describes the energy advancing benefits of a proprietary all natural formula and manufacturing process developed by Health2o Products, LLC over 15 years by its founders. More information is available at

Contact Information